Singapore markets closed

Dentsu Group Inc. (4324.T)

Tokyo - Tokyo Delayed Price. Currency in JPY
Add to watchlist
4,410.00-20.00 (-0.45%)
At close: 03:15PM JST
Full screen
Previous close4,430.00
Open4,430.00
Bid4,405.00 x 0
Ask4,420.00 x 0
Day's range4,385.00 - 4,455.00
52-week range3,500.00 - 5,060.00
Volume1,052,800
Avg. volume938,768
Market cap1.167T
Beta (5Y monthly)1.10
PE ratio (TTM)18.36
EPS (TTM)240.21
Earnings date13 Feb 2023 - 17 Feb 2023
Forward dividend & yield140.50 (3.17%)
Ex-dividend date29 Dec 2022
1y target est5,046.70
  • CNW Group

    DENTSU ANNOUNCES NEW GLOBAL MANAGEMENT STRUCTURE

    Dentsu Group Inc. (Tokyo: 4324) (ISIN: JP3551520004) (President & CEO: Hiroshi Igarashi; Head Office: Tokyo) today announced a globally diverse and integrated leadership team to drive its global business forward from FY2023. The global leadership team will ensure further integration of the Group's diverse capabilities to deliver top line growth for clients, while allowing dentsu to realize sustainable enhancement of corporate value. The creation of a new global management structure follows dents

  • CNW Group

    Dentsu Group Plans Shift to a Globally Integrated Leadership Structure with "One Management Team" to Accelerate Growth

    Dentsu Group Inc. (Tokyo: 4324); (ISIN: JP3551520004); (President & CEO: Hiroshi Igarashi; Head Office: Tokyo; Capital: 74,609.81 million yen; hereinafter referred to as the "Company") today announced its transition to a new globally integrated leadership structure designed to accelerate its business transformation and promote operational excellence. These plans mark a major step forward in the leadership team's ongoing business transformation efforts across the entire group following the launch

  • Business Wire

    Dentsu Health Continues to Bolster its Strategic & Analytical Capabilities with Key Senior Hires

    NEW YORK, May 10, 2022--As part of its ambition and commitment to unlock opportunities for growth and good across the entire healthcare ecosystem, dentsu health announced today two key senior appointments. To elevate dentsu health’s research and audience capabilities, Data Scientist Olympia Mantsios has been appointed Global VP Data & Analytics. And, to accelerate the transformation of dentsu health’s product offerings, Lynda Gordon will join as SVP, Product Development.